Investor Relations & Capital Introduction in Liverpool

Liverpool is a major port city with a distinctive strength in infectious disease research and vaccine manufacturing, alongside maritime, logistics and creative industries. For founders in life sciences and logistics, it offers specialist expertise and regional capital.

Why Liverpool Matters for Capital Raising

The Liverpool School of Tropical Medicine, founded in 1898, was the world's first institution of its kind, and the city remains a leading centre of infection research and vaccine production.

The Port of Liverpool, including its deep-water container terminal opened in 2016, is one of the UK's most important gateways for transatlantic trade.

The University of Liverpool and a strong creative and digital sector add further depth.

What Liverpool Investors Examine

For life sciences businesses, clinical and regulatory pathways are examined closely.

Capital efficiency and commitment to the region are also weighed.

Engagement and Access

GCN connects founders with Liverpool angel investors, family offices and regional allocators, alongside the Manchester investor community, through conference programming and private sessions.

Sectors where we see consistent Liverpool interest include infection research and life sciences, logistics and maritime, creative and digital, advanced manufacturing and clean energy.

Partner with Global Capital Network

Whether you are raising into Liverpool or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.